New York Life Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.2M Sell
343,960
-790
-0.2% -$92.5K 0.31% 64
2026
Q1
$41.5M Buy
344,750
+4,462
+1% +$515K 0.35% 54
2025
Q4
$35.8M Buy
340,288
+1,127
+0.3% +$106K 0.31% 63
2025
Q3
$28.5M Sell
339,161
-6,662
-2% -$549K 0.25% 71
2025
Q2
$27.4M Buy
345,823
+4,031
+1% +$320K 0.26% 77
2025
Q1
$30.7M Sell
341,792
-2,210
-0.6% -$206K 0.31% 60
2024
Q4
$34.2M Buy
344,002
+2,278
+0.7% +$235K 0.33% 47
2024
Q3
$38.8M Sell
341,724
-49,605
-13% -$5.89M 0.38% 47
2024
Q2
$48.4M Buy
391,329
+3,385
+0.9% +$436K 0.49% 34
2024
Q1
$51.2M Sell
387,944
-13,319
-3% -$1.64M 0.51% 36
2023
Q4
$43.7M Buy
401,263
+2,211
+0.6% +$230K 0.45% 37
2023
Q3
$41.1M Sell
399,052
-1,503
-0.4% -$162K 0.44% 40
2023
Q2
$46.2M Sell
400,555
-3,693
-0.9% -$419K 0.48% 36
2023
Q1
$43M Buy
404,248
+274
+0.1% +$29.6K 0.48% 37
2022
Q4
$44.8M Sell
403,974
-691
-0.2% -$70.6K 0.51% 33
2022
Q3
$34.8M Sell
404,665
-1,914
-0.5% -$171K 0.42% 42
2022
Q2
$37.1M Buy
+406,579
New +$36M 0.43% 39
2015
Q4
Sell
-1,362
Closed -$64K 162
2015
Q3
$64K Hold
1,362
0.01% 239
2015
Q2
$74K Buy
+1,362
New +$76.4K 0.01% 236
2014
Q2
Sell
-1,048
Closed -$57K 211
2014
Q1
$57K Hold
1,048
0.01% 154
2013
Q4
$50K Buy
+1,048
New +$47.9K 0.01% 137

Other funds holding MRK

New York Life Investment Management's MRK Position: Q2 2026 in Review

New York Life Investment Management reduced its Merck (MRK) stake by 0.23% in Q2 2026, selling an estimated $92.5K and leaving 343,960 shares worth $44.2M. The position accounts for 0.31% of the portfolio, ranked #64.

New York Life Investment Management first reported a position in MRK in Q4 2013 and has held it in 21 quarters since. The position peaked at $51.2M in Q1 2024. 2,680 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • New York Life Investment Management held 343,960 shares of Merck worth $44.2M as of Q2 2026.
  • New York Life Investment Management sold 790 Merck shares in Q2 2026, an estimated $92.5K.
  • Merck made up 0.31% of New York Life Investment Management's portfolio in Q2 2026, its #64 holding.
  • New York Life Investment Management first reported a position in Merck in Q4 2013 and has held it in 21 quarters since.
  • New York Life Investment Management's Merck position peaked at $51.2M in Q1 2024.
  • 2,680 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.